Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q2 2025 value amounting to 0.13%.

  • Lifecore Biomedical, Inc. \De\'s Return on Invested Capital fell 600.0% to 0.13% in Q2 2025 from the same period last year, while for May 2025 it was 0.13%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.13% for FY2025, which is 500.0% down from last year.
  • As of Q2 2025, Lifecore Biomedical, Inc. \De\'s Return on Invested Capital stood at 0.13%, which was down 600.0% from 0.16% recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s Return on Invested Capital's 5-year high stood at 0.0% during Q4 2021, with a 5-year trough of 0.35% in Q3 2023.
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Return on Invested Capital averaged around 0.11%, with its median value being 0.1% (2024).
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Return on Invested Capital tumbled by -3000bps in 2023 and then skyrocketed by 2500bps in 2024.
  • Lifecore Biomedical, Inc. \De\'s Return on Invested Capital (Quarter) stood at 0.0% in 2021, then tumbled by -79141bps to 0.13% in 2022, then crashed by -105bps to 0.28% in 2023, then skyrocketed by 61bps to 0.11% in 2024, then decreased by -23bps to 0.13% in 2025.
  • Its Return on Invested Capital stands at 0.13% for Q2 2025, versus 0.16% for Q1 2025 and 0.11% for Q4 2024.